Exam 2: MH 701 / MH701 (Latest
Update 2025 / 2026) Psychopharmacologic / Neuroscience Foundations of Mental Health Care | Questions and Answers | 100% Correct - Frontier
Question:
Lithium therapeutic levels
Answer:
0.6-1.2 mEq/L (0.6 - 1 mEq for depression tx; 1-1.5 mEq for mania, maintenance 0.7 - 1 mEq/L)
Question:
Dosing Valproic acid and lamotrigine
Answer:
Valproic acid acts as an inhibitor, therefor dosing of Valproic acid must be titrated slower, decreased to 25 mg every other day for two weeks, then 25 mg daily for two weeks, then 50 mg daily for 2 weeks
- / 3
Question:
Lithium toxicity levels
Answer:
1.5 mEq/L; severe toxicity at < 2 mEq/L
Question:
Patient reports decreased appetite/nausea when taking Lithium
Answer:
hold next dose, check lithium levels
Question:
Frequency of lithium monitoring
Answer:
Weekly until level maintained for 2w. then every 2-3mo. After 1y can do every 6mo.
Additionally, check kidney function on prior to initiation then q 6-12 months, and TSH prior to initiation, at 6 mos, then yearly
- / 3
Question:
Signs of lithium toxicity
Answer:
severe nausea, diarrhea, vomiting, confusion, drowsiness/somnolence, muscle weakness, heart palpitation, coarse hand tremors, unsteady gait
Question:
Carbamazepine therapeutic range
Answer:
4-12 mcg/mL
Question:
valproate therapeutic range
Answer:
50-100 mcg/mL
Question:
Acute dystonia treatment
Answer:
Benztropine, diphenhydramine
- / 3